spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roberts, R. A.
Right arrow Articles by Gullick, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roberts, R. A.
Right arrow Articles by Gullick, W. J.

Journal of Cell Science, Vol 94, Issue 3 527-535, Copyright © 1989 by Company of Biologists


JOURNAL ARTICLES

Bradykinin receptor number and sensitivity to ligand stimulation of mitogenesis is increased by expression of a mutant ras oncogene

RA Roberts and WJ Gullick
Imperial Cancer Research Fund, Hammersmith Hospital, London, UK.

Bradykinin is a nine amino acid peptide of the kinin family believed to play a role in pain mediation and in the regulation of blood pressure, fluid balance and smooth muscle contraction. Here we demonstrate that bradykinin is also a potent mitogen for a mutant Ha-ras-transfected cell line, Rat 13. The Rat 13 cells display two binding sites for bradykinin: a moderate number (52,000) of high affinity sites (Kd = 4.9 nM) co-exist with a much smaller number (1100) of very high-affinity sites (Kd = 2.7 pM). Ligand binding stimulates mitogenesis through the lower affinity receptors, which are classified as B2. These receptors are down-regulated in response to ligand. In contrast, Rat 1 cells (the cell line from which Rat 13 was derived) have only 4000 receptors per cell in total and respond weakly to bradykinin as a mitogen. Thus, expression of a mutant ras protein in Rat 13 cells increases their expression of the bradykinin receptor and their sensitivity to ligand stimulation of mitogenesis. Additional binding studies demonstrate that human A431 epithelial cells and Swiss mouse 3T3 fibroblasts also possess high-affinity sites for bradykinin.


This article has been cited by other articles:


Home page
J EndocrinolHome page
S Greco, C Storelli, and S Marsigliante
Protein kinase C (PKC)-{delta}/-{varepsilon} mediate the PKC/Akt-dependent phosphorylation of extracellular signal-regulated kinases 1 and 2 in MCF-7 cells stimulated by bradykinin
J. Endocrinol., January 1, 2006; 188(1): 79 - 89.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
Z Dlamini and K D Bhoola
Upregulation of tissue kallikrein, kinin B1 receptor, and kinin B2 receptor in mast and giant cells infiltrating oesophageal squamous cell carcinoma
J. Clin. Pathol., September 1, 2005; 58(9): 915 - 922.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
S Greco, M G Elia, A Muscella, S Romano, C Storelli, and S Marsigliante
Bradykinin stimulates cell proliferation through an extracellular-regulated kinase 1 and 2-dependent mechanism in breast cancer cells in primary culture
J. Endocrinol., August 1, 2005; 186(2): 291 - 301.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
L. M. F. Leeb-Lundberg, F. Marceau, W. Muller-Esterl, D. J. Pettibone, and B. L. Zuraw
International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences
Pharmacol. Rev., March 1, 2005; 57(1): 27 - 77.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. A. Baptista, M. C. W. Avellar, R. C. Araujo, J. L. Pesquero, J. P. Schanstra, J. L. Bascands, J. P. Esteve, A. C. M. Paiva, M. Bader, and J. B. Pesquero
Transcriptional Regulation of the Rat Bradykinin B2 Receptor Gene: Identification of a Silencer Element
Mol. Pharmacol., December 1, 2002; 62(6): 1344 - 1355.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
G. M. Yousef and E. P. Diamandis
The New Human Tissue Kallikrein Gene Family: Structure, Function, and Association to Disease
Endocr. Rev., April 1, 2001; 22(2): 184 - 204.
[Abstract] [Full Text]


Home page
J. Cell Sci.Home page
M Haasemann, J Cartaud, W Muller-Esterl, and I Dunia
Agonist-induced redistribution of bradykinin B2 receptor in caveolae
J. Cell Sci., January 4, 1998; 111(7): 917 - 928.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
B. Schindelholz and B. F. X. Reber
Bradykinin-Induced Collapse of Rat Pheochromocytoma (PC12) Cell Growth Cones: A Role for Tyrosine Kinase Activity
J. Neurosci., November 1, 1997; 17(21): 8391 - 8401.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. N. Prado, L. Taylor, and P. Polgar
Effects of Intracellular Tyrosine Residue Mutation and Carboxyl Terminus Truncation on Signal Transduction and Internalization of the Rat Bradykinin B2 Receptor
J. Biol. Chem., June 6, 1997; 272(23): 14638 - 14642.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Blaukat, S. A. Alla, M. J. Lohse, and W. Muller-Esterl
Ligand-induced Phosphorylation/Dephosphorylation of the Endogenous Bradykinin B2 Receptor from Human Fibroblasts
J. Biol. Chem., December 13, 1996; 271(50): 32366 - 32374.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. C. Chen, L. Chao, and J. Chao
Roles of the P1, P2, and P3 Residues in Determining Inhibitory Specificity of Kallistatin toward Human Tissue Kallikrein
J. Biol. Chem., December 1, 2000; 275(49): 38457 - 38466.
[Abstract] [Full Text] [PDF]




© The Company of Biologists Ltd 1989